516 Chapter | 16 Kidney Function and Damage Eriksson , L. , and Valtonen , M. ( 1982 ). Renal urea handling in goats fed high and low protein diets . J. Dairy Sci. 65 , 385 – 389 . Evans , G. O. ( 1987 ). Post-prandial changes in canine plasma creatinine . J. Small. Anim. Pract. 28 , 311 – 315 . Ewald , B. H. ( 1967 ). Renal function tests in normal Beagle dogs . Am. J. Vet. Res. 28 , 741 – 749 . Faulks , R. D. , and Lane , I. F. ( 2003 ). Qualitative urinalyses in puppies 0 to 24 weeks <strong>of</strong> age . J. Am. Anim. Hosp. Assoc. 39 , 369 – 378 . Feeman , W. E. , 3rd , Couto , C. G. , and Gray , T. L. ( 2003 ). Serum creatinine concentrations in retired racing Greyhounds . Vet. Clin. Pathol. 32 , 40 – 42 . Feeney , D. A. , Osborne , C. A. , and Jessen , C. R. ( 1980 a ). Effect <strong>of</strong> multiple excretory urograms on glomerular filtration <strong>of</strong> normal dogs: a preliminary report . Am. J. Vet. Res. 41 , 960 – 963 . Feeney , D. A. , Osborne , C. A. , and Jessen , C. R. (1980b ). Effects <strong>of</strong> radiographic contrast media on results <strong>of</strong> urinalysis, with emphasis on alteration in specific gravity . J. Am. Vet. Med. Assoc. 176 , 1378 –1381 . Feraille , E. , and Doucet , A. ( 2001 ). Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control . Physiol. Rev. 81 , 345 – 418 . Fetcher , A. ( 1985 ). Renal disease in cattle. Causative agents . Comp. Cont. Educ. Pract. Vet. 7 , S701 – S707 . Fetcher , A. ( 1986 ). Renal disease in cattle. Part II. <strong>Clinical</strong> signs, diagnosis, and treatment . Comp. Cont. Educ. Pract. Vet. 8 , S338 – S345 . Fettman , M. J. ( 1987 ). Evaluation <strong>of</strong> the usefulness <strong>of</strong> routine microscopy in canine urinalysis . J. Am. Vet. Med. Assoc. 190 , 892 – 896 . Fettman , M. J. ( 1989 ). Comparison <strong>of</strong> urinary protein concentration and protein/creatinine ratio vs routine microscopy in urinalysis <strong>of</strong> dogs: 500 cases (1987–1988) . J. Am. Vet. Med. Assoc. 195 , 926 – 972 . Fettman , M. J. , Allen , T. A. , Wilke , W. L. , et al. ( 1985 ). Single-injection method for evaluation <strong>of</strong> renal function with 14C-inulin and 3Htetraethylammonium bromide in dogs and cats . Am. J. Vet. Res. 46 , 482 – 485 . Filippich , L. J. ( 1992 ). Renal clearance studies in cats with chronic renal disease: dietary implications . J. Small. Anim. Pract. 33 , 191 – 196 . Filippich , L. J. , English , P. B. , and Ainscow , J. ( 1985 ). Assessment <strong>of</strong> compensatory renal function and [125I]iothalamate clearance in sheep . Am. J. Vet. Res. 46 , 2311 – 2316 . Filler , G. , Bokenkamp , A. , H<strong>of</strong>mann , W. , Le Bricon , T. , Martinez-Bru , C. , and Grubb , A. ( 2005 ). Cystatin C as a marker <strong>of</strong> GFR—history, indications, and future research . Clin. Biochem. 38 , 1 – 8 . Finco , D. R. (2004 ). Association <strong>of</strong> systemic hypertension with renal injury in dogs with induced renal failure . J. Vet. Intern. Med. 18 , 289 – 294 . Finco , D. R. ( 1995 a ). Evaluation <strong>of</strong> renal functions . In “ Canine and Feline Nephrology and Urology ” ( C. A. Osborne and D. R. Finco , Eds.) , pp. 216 – 229 . Williams and Wilkins , Baltimore . Finco , D. R. ( 1995 b ). Kidney function . In “ <strong>Clinical</strong> <strong>Biochemistry</strong> <strong>of</strong> <strong>Domestic</strong> <strong>Animals</strong> ” ( J. J. Kaneko , J. W. Harvey , and M. L. Bruss , Eds.) , 5th ed . , pp. 441 – 484 . Academic Press , San Diego, CA . Finco , D. R. ( 2005 ). Measurement <strong>of</strong> glomerular filtration rate via urinary clearance <strong>of</strong> inulin and plasma clearance <strong>of</strong> Tc 99m pentetate and exogenous creatinine in dogs . Am. J. Vet. Res. 66 , 1046 – 1055 . Finco , D. R. ( 1971 ). Simultaneous determination <strong>of</strong> phenolsulonphtalein excretion and endogenous creatinine clearance in the normal dog . J. Am. Vet. Med. Assoc. 159 , 336 – 340 . Finco , D. R. , Adams , D. D. , Crowelle , W. A. , Stattelman , A. J. , Brown , S. A. , and Barsanti , J. A. ( 1986 ). Food and water intake and urine composition in cats: influence <strong>of</strong> continuous versus periodic feeding . Am. J. Vet. Res. 47 , 1638 – 1642 . Finco , D. R. , and Barsanti , J. A. ( 1982 ). Mechanism <strong>of</strong> urinary excretion <strong>of</strong> creatinine by the cat . Am. J. Vet. Res. 43 , 2207 – 2209 . Finco , D. R. , and Barsanti , J. A. ( 1989 ). <strong>Clinical</strong> evaluation <strong>of</strong> renal function . In “ Current Veterinary Therapy X Small Animal Practice ” ( R. W. Kirk and J. D. Bonagura , Eds.) , pp. 1123 – 1126 . Saunders , Philadelphia . Finco , D. R. , Barsanti , J. A. , and Brown , S. A. ( 1989 ). Influence <strong>of</strong> dietary source <strong>of</strong> phosphorus on fecal and urinary excretion <strong>of</strong> phosphorus and other minerals by male cats . Am. J. Vet. Res. 50 , 263 – 266 . Finco , D. R. , Barsanti , J. A. , and Brown , S. A. ( 1992 a ). Solute fractional excretion rates . In “ Current Veterinary Therapy XI ” ( R. W. Kirk and J. D. Bonagura , Eds.) , pp. 818 – 820 . Saunders , Philadelphia . Finco , D. R. , Braselton , W. E. , and Cooper , T. A. ( 2001 ). Relationship between plasma iohexol clearance and urinary exogenous creatinine clearance in dogs . J. Vet. Intern. Med. 15 , 368 – 573 . Finco , D. R. , Brown , S. A. , Barsanti , J. A. , Bartges , J. W. , and Cooper , T. A. ( 1997 ). Reliability <strong>of</strong> using random urine samples for “ spot ” determination <strong>of</strong> fractional excretion <strong>of</strong> electrolytes in cats . Am. J. Vet. Res. 58 , 1184 – 1187 . Finco , D. R. , Brown , S. A. , Brown , C. A. , Crowell , W. A. , Cooper , T. A. , and Barsanti , J. A. ( 1999 ). Progression <strong>of</strong> chronic renal disease in the dog . J. Vet. Intern. Med. 13 , 516 – 528 . Finco , D. R. , Brown , S. A. , Crowell , W. A. , and Barsanti , J. A. ( 1991 ). Exogenous creatinine clearance as a measure <strong>of</strong> glomerular filtration rate in dogs with reduced renal mass . Am. J. Vet. Res. 52 , 1029 – 1032 . Finco , D. R. , Brown , S. A. , Crowell , W. A. , Groves , C. A. , Duncan , J. R. , and Barsanti , J. A. ( 1992 b ). Effects <strong>of</strong> phosphorus/calcium-restricted and phosphorus/calcium-replete 32% protein diets in dogs with chronic renal failure . Am. J. Vet. Res. 53 , 157 – 163 . Finco , D. R. , Brown , S. A. , Vaden , S. L. , and Ferguson , D. C. ( 1995 ). Relationship between plasma creatinine concentration and glomerular filtration rate in dogs . J. Vet. Pharmacol. Ther. 18 , 418 – 421 . Finco , D. R. , Brown , S. A. , Crowell , W. A. , et al. ( 1994 ). Effects <strong>of</strong> aging and dietary protein intake on uninephrectomized geriatric dogs . Am J Vet Res 55 , 1282 – 1290 . Finco , D. R. , Brown , S. A. , Brown , C. A. , et al. ( 1998 ). Protein and calorie effects on progression <strong>of</strong> induced chronic renal failure in cats . Am. J. Vet. Res. 59 , 575 – 582 . Finco , D. R. , and Cooper , T. L. ( 2000 ). Soy protein increases glomerular filtration rate in dogs with normal or reduced renal function . J. Nutr. 130 , 745 – 748 . Finco , D. R. , Coulter , D. B. , and Barsanti , J. A. ( 1981 ). Simple, accurate method for clinical estimation <strong>of</strong> glomerular filtration rate in the dog . Am. J. Vet. Res. 42 , 1874 – 1877 . Finco , D. R. , and Duncan , J. R. ( 1972 ). Relationship <strong>of</strong> glomerular number and diameter to body size <strong>of</strong> the dog . Am. J. Vet. Res. 33 , 2447 – 2450 . Finco , D. R. , and Duncan , J. R. ( 1976 ). Evaluation <strong>of</strong> blood urea nitrogen and serum creatinine concentrations as indicators <strong>of</strong> renal dysfunction: a study <strong>of</strong> 111 cases and a review <strong>of</strong> related literature . J. Am. Vet. Med. Assoc. 168 , 593 – 601 . Finco , D. R. , and Groves , C. ( 1985 ). Mechanism <strong>of</strong> renal excretion <strong>of</strong> creatinine by the pony . Am. J. Vet. Res. 46 , 1625 – 1628 . Finco , D. R. , Tabaru , H. , Brown , S. A. , and Barsanti , J. A. ( 1993 ). Endogenous creatinine clearance measurement <strong>of</strong> glomerular filtration rate in dogs . Am. J. Vet. Res. 54 , 1575 – 1578 . Fine , A. ( 1991 ). Remnant kidney metabolism in the dog . J. Am. Soc. Nephrol. 2 , 70 – 76 . Fisher , J. W. (2003 ). Erythropoietin: physiology and pharmacology update . Exp. Biol. Med. (Maywood) 228 , 1 – 14 .
References 517 Fleming , S. A. , Hunt , E. L. , Brownie , C. , Rakes , A. , and McDaniel , B. ( 1992 ). Fractional excretion <strong>of</strong> electrolytes in lactating dairy cows . Am. J. Vet. Res. 53 , 222 – 224 . Fleming , S. A. , Hunt , E. L. , Riviere , J. E. , and Anderson , K. L. ( 1991 ). Renal clearance and fractional excretion <strong>of</strong> electrolytes over four 6-hour periods in cattle . Am. J. Vet. Res. 52 , 5 – 8 . Forrester , S. D. ( 2004 ). Diagnostic approach to hematuria in dogs and cats . Vet. Clin. North. Am. Small. Anim. Pract. 34 , 849 – 866 . Forrester , S. D. , Fallin , E. A. , Saunders , G. K. , and Kenny , J. E. ( 1993 ). Prevention <strong>of</strong> cisplatin-induced nephrotoxicosis in dogs, using hypertonic saline solution as the vehicle <strong>of</strong> administration . Am. J. Vet. Res. 54 , 2175 – 2178 . Forsyth , S. F. , Guilford , W. G. , and Pfeiffer , D. U. ( 2000 ). Effect <strong>of</strong> NSAID administration on creatinine clearance in healthy dogs undergoing anesthesia and surgery . J. Small. Anim. Pract. 41 , 547 – 550 . Forterre , S. , Raila , J. , and Schweigert , F. J. ( 2004 ). Protein pr<strong>of</strong>iling <strong>of</strong> urine from dogs with renal disease using ProteinChip analysis . J. Vet. Diagn. Invest. 16 , 271 – 277 . Fox , L. E. , Grauer , G. F. , Dubielzig , R. R. , and Bjorling , D. E. ( 1987 ). Reversal <strong>of</strong> ethylene glycol-induced nephrotoxicosis in a dog . J. Am. Vet. Med. Assoc. 191 , 1433 – 1435 . Frazier , D. L. , Dix , L. P. , Bowman , K. F. , Thompson , C. , and Riviere , J. E. ( 1986 ). Increased gentamicin nephrotoxicity in normal and diseased dogs administered identical serum drug concentration pr<strong>of</strong>iles: increased sensitivity in subclinical renal dysfunction . J. Pharmacol. Exp. Ther. 239 , 946 – 951 . Freeman , L. M. , Breitschwerdt , E. B. , Keene , B. W. , and Hansen , B. (1994 ). Fanconi’s syndrome in a dog with primary hypoparathyroidism . J. Vet. Intern. Med. 8 , 349 – 354 . Fukuda , S. , Kawashima , N. , Iida , H. , Aoki , J. , and Tokita , K. ( 1989 ). Age dependency <strong>of</strong> hematological values and concentrations <strong>of</strong> serum biochemical constituents in normal Beagles from 1 to 14 years <strong>of</strong> age . Jpn. J. Vet. Sci. 51 , 636 – 641 . Gabrisch , K. ( 1973 ). Serumharnst<strong>of</strong>f und Serumkreatinine als Indikatoren der Nierenfunktion beim Hund . Kleintier. Praxis 18 , 133 – 135 . Gagnon , J. A. , Felipe , I. , Nelson , L. D. , and Butkus , D. E. ( 1982 ). Infl uence <strong>of</strong> thiopental anesthesia on renal sodium and water excretion in the dog . Am. J. Physiol. 243 , F265 – F270 . Gagnon , J. A. , Schrier , R. W. , Weis , T. P. , Kokotis , W. , and Mailloux , L. U. ( 1971 ). Clearance <strong>of</strong> iothalamate-125 I as a measure <strong>of</strong> glomerular filtration rate in the dog . J. Appl. Physiol. 30 , 774 – 778 . Gans , J. H. ( 1975 ). Effects <strong>of</strong> triamcinolone and <strong>of</strong> desoxycorticosterone on renal function in sheep . Proc. Soc. Exp. Biol. Med. 150 , 244 – 248 . Garry , F. , Chew , D. J. , and H<strong>of</strong>fsis , G. F. ( 1990 a ). Enzymuria as an index <strong>of</strong> renal damage in sheep with induced aminoglycoside nephrotoxicosis . Am. J. Vet. Res. 51 , 428 – 432 . Garry , F. , Chew , D. J. , and H<strong>of</strong>fsis , G. F. ( 1990 b ). Urinary indices <strong>of</strong> renal function in sheep with induced aminoglycoside nephrotoxicosis . Am. J. Vet. Res. 51 , 420 – 427 . Garry , F. , Chew , D. J. , Rings , D. M. , Tarr , M. J. , and H<strong>of</strong>fsis , G. F. ( 1990 c ). Renal excretion <strong>of</strong> creatinine, electrolytes, protein, and enzymes in healthy sheep . Am. J. Vet. Res. 51 , 414 – 419 . Gartner , K. , Reulecke , W. , Hackbarth , H. , and Wollnik , F. ( 1987 ). Zur Abhängigkeit von Muskelmasse und Körpergrösse im Vergleich von Maus, Ratte, Kaninchen, Hund, Mensch, und Pferd . Dtsch. Tierärztl. Wschr. 94 , 52 – 53 . Gartner , W. (1981 ). Zur physiologischen Ausscheidung von Plasmaeiveiss mit dem Harn bei gesunden Tieren . Dtsch. Tieräztl. Wschr. 88 , 420 – 422 . Gary , A. T. , Cohn , L. A. , Kerl , M. E. , and Jensen , W. A. ( 2004 ). The effects <strong>of</strong> exercise on urinary albumin excretion in dogs . J. Vet. Intern. Med. 18 , 52 – 55 . Gasthuys , F. , Terpstra , P. , van den Hende , C. , and De Moor , A. ( 1987 ). Hyperglycaemia and diuresis during sedation with detomidine in the horse . Zentralbl. Veterinarmed. A 34 , 641 – 648 . Gasthuys , F. , van den Hende , C. , and de Moor , A. (1986 ). Study <strong>of</strong> some ionary parameters in horse serum and urine during halothane anaesthesia with xylazine premedication . Zentralbl. Veterinarmed. A 33 , 791 –800 . Gekle , M. ( 1998 ). Renal proximal tubular albumin reabsorption: daily prevention <strong>of</strong> albuminuria . News. Physiol. Sci. 13 , 5 – 11 . Gelsa , H. ( 1979 ). The renal clearance <strong>of</strong> inulin, creatinine, trimethoprim and sulphadoxine in horses . J. Vet. Pharamacol. Therap. 2 , 257 – 264 . Genetzky , R. M. , Loparco , F. V. , and Ledet , A. E. ( 1987 ). <strong>Clinical</strong> pathologic alterations in horses during a water deprivation test . Am. J. Vet. Res. 48 , 1007 – 1011 . George , J. W. ( 2001 ). The usefulness and limitations <strong>of</strong> hand-held refractometers in veterinary laboratory medicine: an historical and technical review . Vet. Clin. Pathol. 30 , 201 – 210 . Gimonet , V. , Bussieres , L. , Medjebeur , A. A. , Gasser , B. , Lelongt , B. , and Laborde , K. ( 1998 ). Nephrogenesis and angiotensin II receptor subtypes gene expression in the fetal lamb . Am. J. Physiol. 274 , F1062 – F1069 . Gleadhill , A. ( 1994 ). Evaluation <strong>of</strong> screening tests for renal insufficiency in the dog . J. Small. Anim. Pract. 35 , 391 – 396 . Gleadhill , A. , Marlin , D. , Harris , P. A. , and Michell , A. R. ( 1999 ). Use <strong>of</strong> a three-blood-sample plasma clearance technique to measure GFR in horses . Vet. J. 158 , 204 – 209 . Gleadhill , A. , and Michell , A. R. ( 1996 ). Evaluation <strong>of</strong> iohexol as a marker for the clinical measurement <strong>of</strong> glomerular filtration rate in dogs . Res. Vet. Sci. 60 , 117 – 121 . Gobar , G. M. , Case , J. T. , and Kass , P. H. ( 1998 ). Program for surveillance <strong>of</strong> causes <strong>of</strong> death <strong>of</strong> dogs, using the Internet to survey small animal veterinarians . J. Am. Vet. Med. Assoc. 213 , 251 – 256 . Godeau , J. M. , Dehareng , D. , Beaussart , F. , Ndibualonji , B. , and Debue , P. (1990 ). Mesure nychtémérale de la clairance rénale de l’urée chez la vache sondée: influence des hématuries accidentelles . Ann. Méd. Vét. 134 , 455 – 463 . Goldfarb , S. , Westby , G. R. , Goldberg , M. , and Agus , Z. S. ( 1977 ). Renal tubular effects <strong>of</strong> chronic phosphate depletion . J. Clin. Invest. 59 , 770 – 779 . Gossett , K. A. , Turnwald , G. H. , Kearney , M. T. , Greco , D. S. , and Cleghorn , B. (1987 ). Evaluation <strong>of</strong> gamma-glutamyl transpeptidase-tocreatinine ratio from spot samples <strong>of</strong> urine supernatant, as an indicator <strong>of</strong> urinary enzyme excretion in dogs . Am. J. Vet. Res. 48 , 455 –457 . Gouda , I. M. , Abdel Aziz , S. A. , L<strong>of</strong>ti , M. M. , Ahmed , A. A. , and Soliman , M. M. ( 1986 ). Changes in some kidney functions in experimentally lead-poisoned goats . Arch. Exp. Veterinarmed. 40 , 242 – 249 . Gougoux , A. , Zan , N. , Dansereau , D. , and Vinay , P. ( 1989 ). Experimental Fanconi’s syndrome resulting from 4-pentenoate infusion in the dog . Am. J. Physiol. 257 , F959 – F966 . Grauer , G. F. ( 1985 ). Clinicopathologic evaluation <strong>of</strong> early renal disease in dogs . Comp. Cont. Educ. Pract. Vet. 7 , 32 – 38 . Grauer , G. F. ( 1996 ). Prevention <strong>of</strong> acute renal failure . Vet. Clin. North. Am. Small. Anim. Pract. 26 , 1447 – 1459 . Grauer , G. F. ( 2005 ). Canine glomerulonephritis: new thoughts on proteinuria and treatment . J. Small. Anim. Pract. 46 , 469 – 478 . Grauer , G. F. , and DiBartola , S. P. ( 2000 ). Glomerular disease . In “ Textbook <strong>of</strong> Veterinary Internal Medicine ” ( S. J. Ettinger and E. C. Feldman , Eds.) , 5th ed . , pp. 1662 – 1678 . Saunders , Philadelphia .
- Page 1 and 2:
Preface It has been more than a dec
- Page 3 and 4:
viii Contributors Björn P. Meij (5
- Page 5 and 6:
2 Chapter | 1 Concepts of Normality
- Page 7 and 8:
4 Chapter | 1 Concepts of Normality
- Page 9 and 10:
6 Chapter | 1 Concepts of Normality
- Page 11 and 12:
8 Chapter | 1 Concepts of Normality
- Page 13 and 14:
10 Chapter | 1 Concepts of Normalit
- Page 15 and 16:
12 Chapter | 1 Concepts of Normalit
- Page 17 and 18:
14 Chapter | 1 Concepts of Normalit
- Page 19 and 20:
16 Chapter | 1 Concepts of Normalit
- Page 21 and 22:
18 Chapter | 1 Concepts of Normalit
- Page 23 and 24:
20 Chapter | 1 Concepts of Normalit
- Page 25 and 26:
22 Chapter | 1 Concepts of Normalit
- Page 27 and 28:
24 Chapter | 1 Concepts of Normalit
- Page 29 and 30:
Chapter 2 Comparative Medical Genet
- Page 31 and 32:
I. Introduction 29 Green Red Green
- Page 33 and 34:
I. Introduction 31 A1 genetic map d
- Page 35 and 36:
I. Introduction 33 of genomes of va
- Page 38 and 39:
36 Chapter | 2 Comparative Medical
- Page 40 and 41:
38 Chapter | 2 Comparative Medical
- Page 42 and 43:
40 Chapter | 2 Comparative Medical
- Page 44 and 45:
42 Chapter | 2 Comparative Medical
- Page 46 and 47:
44 Chapter | 2 Comparative Medical
- Page 48 and 49:
46 Chapter | 3 Carbohydrate Metabol
- Page 50 and 51:
48 Chapter | 3 Carbohydrate Metabol
- Page 52 and 53:
50 Chapter | 3 Carbohydrate Metabol
- Page 54 and 55:
52 Chapter | 3 Carbohydrate Metabol
- Page 56 and 57:
54 Chapter | 3 Carbohydrate Metabol
- Page 58 and 59:
56 Chapter | 3 Carbohydrate Metabol
- Page 60 and 61:
58 Chapter | 3 Carbohydrate Metabol
- Page 62 and 63:
60 Chapter | 3 Carbohydrate Metabol
- Page 64 and 65:
62 Chapter | 3 Carbohydrate Metabol
- Page 66 and 67:
64 Chapter | 3 Carbohydrate Metabol
- Page 68 and 69:
66 Chapter | 3 Carbohydrate Metabol
- Page 71 and 72:
IX. Disorders of Carbohydrate Metab
- Page 73 and 74:
IX. Disorders of Carbohydrate Metab
- Page 75 and 76:
IX. Disorders of Carbohydrate Metab
- Page 77 and 78:
X. Disorders of Ruminants Associate
- Page 79 and 80:
X. Disorders of Ruminants Associate
- Page 81 and 82:
References 79 Kaneko , J. J. , Luic
- Page 83 and 84:
Chapter 4 Lipids and Ketones Michae
- Page 85 and 86:
II. Long Chain Fatty Acids 83 FIGUR
- Page 87 and 88:
II. Long Chain Fatty Acids 85 Plasm
- Page 89 and 90:
IV. Phospholipids 87 The regulation
- Page 91 and 92:
V. Cholesterol 89 V. CHOLESTEROL A.
- Page 93 and 94:
VI. Lipoproteins 91 TABLE 4-1 Compo
- Page 95 and 96:
VI. Lipoproteins 93 TABLE 4-2 Apoli
- Page 98 and 99:
96 Chapter | 4 Lipids and Ketones B
- Page 100 and 101:
98 Chapter | 4 Lipids and Ketones
- Page 102 and 103:
100 Chapter | 4 Lipids and Ketones
- Page 104 and 105:
102 Chapter | 4 Lipids and Ketones
- Page 106 and 107:
104 Chapter | 4 Lipids and Ketones
- Page 108 and 109:
106 Chapter | 4 Lipids and Ketones
- Page 110 and 111:
108 Chapter | 4 Lipids and Ketones
- Page 112 and 113:
110 Chapter | 4 Lipids and Ketones
- Page 114 and 115:
112 Chapter | 4 Lipids and Ketones
- Page 116 and 117:
114 Chapter | 4 Lipids and Ketones
- Page 118 and 119:
Chapter 5 Proteins, Proteomics, and
- Page 120 and 121:
III. Metabolism of Proteins 119 C .
- Page 122 and 123:
IV. Plasma Proteins 121 NH 4 HCO
- Page 124 and 125:
V. Methodology 123 molecule. The gl
- Page 126 and 127:
V. Methodology 125 has occurred wil
- Page 128 and 129:
V. Methodology 127 Although attempt
- Page 130 and 131:
V. Methodology 129 kD 94 67 43 2 2
- Page 132 and 133:
V. Methodology 131 D . Specific Pro
- Page 134 and 135:
VI. Normal Plasma and Serum Protein
- Page 136 and 137:
VI. Normal Plasma and Serum Protein
- Page 138 and 139:
VI. Normal Plasma and Serum Protein
- Page 140 and 141:
VI. Normal Plasma and Serum Protein
- Page 142 and 143:
VI. Normal Plasma and Serum Protein
- Page 144 and 145:
VII. Interpretation of Serum Protei
- Page 146 and 147:
VII. Interpretation of Serum Protei
- Page 148 and 149:
VII. Interpretation of Serum Protei
- Page 150 and 151:
References 149 Andersson , M. , Ste
- Page 152 and 153:
References 151 response of haptoglo
- Page 154 and 155:
References 153 dogs with metastasiz
- Page 156 and 157:
References 155 Watson , T. D. G. (
- Page 158:
158 Chapter | 6 Clinical Veterinary
- Page 163 and 164:
V. Methods for Evaluation of the Im
- Page 165 and 166:
V. Methods for Evaluation of the Im
- Page 167 and 168:
V. Methods for Evaluation of the Im
- Page 169:
VI. Laboratory Diagnosis of Disease
- Page 173 and 174:
Chapter 7 The Erythrocyte: Physiolo
- Page 175 and 176:
II. Hematopoiesis 175 progenitor ce
- Page 177 and 178:
III. Developing Erythroid Cells 177
- Page 179 and 180:
III. Developing Erythroid Cells 179
- Page 181 and 182:
III. Developing Erythroid Cells 181
- Page 183 and 184:
III. Developing Erythroid Cells 183
- Page 185 and 186:
IV. Mature RBC 185 immune-mediated
- Page 187 and 188:
IV. Mature RBC 187 TABLE 7-3 Erythr
- Page 189 and 190:
IV. Mature RBC 189 TABLE 7.5 Erythr
- Page 191 and 192:
IV. Mature RBC 191 Echinocyte forma
- Page 193 and 194:
IV. Mature RBC 193 Pig RBC isoantig
- Page 195 and 196:
IV. Mature RBC 195 occurs in chicke
- Page 197 and 198:
IV. Mature RBC 197 inorganic phosph
- Page 199 and 200:
IV. Mature RBC 199 (a) FIGURE 7-6 T
- Page 201 and 202:
IV. Mature RBC 201 RBC 2,3DPG incre
- Page 203 and 204:
IV. Mature RBC 203 mechanisms would
- Page 205 and 206:
IV. Mature RBC 205 released during
- Page 207 and 208:
IV. Mature RBC 207 reduced by ascor
- Page 209 and 210:
V. Determinants of RBC Survival 209
- Page 211 and 212:
V. Determinants of RBC Survival 211
- Page 213 and 214:
VI. Inherited Disorders of RBCs 213
- Page 215 and 216:
VI. Inherited Disorders of RBCs 215
- Page 217 and 218:
VI. Inherited Disorders of RBCs 217
- Page 219 and 220:
described in people. They include a
- Page 221 and 222:
References 221 Boas , F. E. , Forma
- Page 223 and 224:
References 223 Della Rovere , F. ,
- Page 225 and 226:
References 225 Gedde , M. M. , Davi
- Page 227 and 228:
References 227 phosphofructokinase-
- Page 229 and 230:
References 229 Knight , A. P. , Las
- Page 231 and 232:
References 231 Martinovich , D. , a
- Page 233 and 234:
References 233 Pearson , W. , Boerm
- Page 235 and 236:
References 235 Shadduck , R. K. ( 1
- Page 237 and 238:
References 237 Tennant , B. , Dill
- Page 239 and 240:
References 239 Williams , D. M. , L
- Page 241 and 242:
Chapter 8 Porphyrins and the Porphy
- Page 243 and 244:
II. Porphyrins 243 two vinyl groups
- Page 245 and 246:
II. Porphyrins 245 TABLE 8-2 Nomenc
- Page 247 and 248:
IV. Porphyrias 247 6. Uroporphyrins
- Page 249 and 250:
IV. Porphyrias 249 i . Urine It is
- Page 251 and 252:
IV. Porphyrias 251 to localize the
- Page 253 and 254:
IV. Porphyrias 253 FIGURE 8-6 Metab
- Page 255 and 256:
IV. Porphyrias 255 estrogens. The d
- Page 257 and 258:
References 257 and hexachlorobenzen
- Page 259 and 260:
Chapter 9 Iron Metabolism and Its D
- Page 261 and 262:
II. Iron Distribution 261 plasma of
- Page 263 and 264:
IV. Plasma Iron Transport 263 pathw
- Page 265 and 266:
VI. Iron Metabolism in Cells 265 of
- Page 267 and 268:
VI. Iron Metabolism in Cells 267 in
- Page 269 and 270:
VII. Tests for Evaluating Iron Meta
- Page 271 and 272:
VII. Tests for Evaluating Iron Meta
- Page 273 and 274:
VIII. Disorders of Iron Metabolism
- Page 275 and 276:
VIII. Disorders of Iron Metabolism
- Page 277 and 278:
VIII. Disorders of Iron Metabolism
- Page 279 and 280:
References 279 ( Norrdin et al ., 2
- Page 281 and 282:
References 281 Fresco , R. ( 1981 )
- Page 283 and 284:
References 283 Moore , C. V. , Duba
- Page 285 and 286:
References 285 Weiden , P. L. , Hac
- Page 287 and 288:
288 Chapter | 10 Hemostasis TABLE 1
- Page 289 and 290:
290 Chapter | 10 Hemostasis TABLE 1
- Page 291 and 292:
292 Chapter | 10 Hemostasis The pro
- Page 293 and 294:
294 Chapter | 10 Hemostasis exhibit
- Page 295 and 296:
296 Chapter | 10 Hemostasis TABLE 1
- Page 297 and 298:
298 Chapter | 10 Hemostasis that is
- Page 299 and 300:
300 Chapter | 10 Hemostasis TABLE 1
- Page 301 and 302:
302 Chapter | 10 Hemostasis However
- Page 303 and 304:
304 Chapter | 10 Hemostasis 2. Comp
- Page 305 and 306:
306 Chapter | 10 Hemostasis is a re
- Page 307 and 308:
308 Chapter | 10 Hemostasis 2. Asse
- Page 309 and 310:
310 Chapter | 10 Hemostasis necessi
- Page 311 and 312:
312 Chapter | 10 Hemostasis disease
- Page 313 and 314:
314 Chapter | 10 Hemostasis concent
- Page 315 and 316:
316 Chapter | 10 Hemostasis the rol
- Page 317 and 318:
318 Chapter | 10 Hemostasis proport
- Page 319 and 320:
320 Chapter | 10 Hemostasis a consi
- Page 321 and 322:
322 Chapter | 10 Hemostasis Bakhtia
- Page 323 and 324:
324 Chapter | 10 Hemostasis Dowd ,
- Page 325 and 326:
326 Chapter | 10 Hemostasis Kier ,
- Page 327 and 328:
328 Chapter | 10 Hemostasis Nielsen
- Page 329 and 330:
330 Chapter | 10 Hemostasis Tablin
- Page 331 and 332:
332 Chapter | 11 Neutrophil Functio
- Page 333 and 334:
334 Chapter | 11 Neutrophil Functio
- Page 335 and 336:
336 Chapter | 11 Neutrophil Functio
- Page 337 and 338:
338 Chapter | 11 Neutrophil Functio
- Page 339 and 340:
340 Chapter | 11 Neutrophil Functio
- Page 341 and 342:
342 Chapter | 11 Neutrophil Functio
- Page 343 and 344:
344 Chapter | 11 Neutrophil Functio
- Page 345 and 346:
346 Chapter | 11 Neutrophil Functio
- Page 347 and 348:
348 Chapter | 11 Neutrophil Functio
- Page 349 and 350:
350 Chapter | 11 Neutrophil Functio
- Page 351 and 352:
352 Chapter | 12 Diagnostic Enzymol
- Page 353 and 354:
354 Chapter | 12 Diagnostic Enzymol
- Page 355 and 356:
356 Chapter | 12 Diagnostic Enzymol
- Page 357 and 358:
358 Chapter | 12 Diagnostic Enzymol
- Page 359 and 360:
360 Chapter | 12 Diagnostic Enzymol
- Page 361 and 362:
362 Chapter | 12 Diagnostic Enzymol
- Page 363 and 364:
364 Chapter | 12 Diagnostic Enzymol
- Page 365 and 366:
366 Chapter | 12 Diagnostic Enzymol
- Page 367 and 368:
368 Chapter | 12 Diagnostic Enzymol
- Page 369 and 370:
370 Chapter | 12 Diagnostic Enzymol
- Page 371 and 372:
372 Chapter | 12 Diagnostic Enzymol
- Page 373 and 374:
374 Chapter | 12 Diagnostic Enzymol
- Page 375 and 376:
376 Chapter | 12 Diagnostic Enzymol
- Page 377 and 378:
378 Chapter | 12 Diagnostic Enzymol
- Page 379 and 380:
380 Chapter | 13 Hepatic Function L
- Page 381 and 382:
382 Chapter | 13 Hepatic Function e
- Page 383 and 384:
384 Chapter | 13 Hepatic Function p
- Page 385 and 386:
386 Chapter | 13 Hepatic Function m
- Page 387 and 388:
388 Chapter | 13 Hepatic Function s
- Page 389 and 390:
390 Chapter | 13 Hepatic Function f
- Page 391 and 392:
392 Chapter | 13 Hepatic Function T
- Page 393 and 394:
394 Chapter | 13 Hepatic Function 2
- Page 395 and 396:
396 Chapter | 13 Hepatic Function u
- Page 397 and 398:
398 Chapter | 13 Hepatic Function 2
- Page 399 and 400:
400 Chapter | 13 Hepatic Function c
- Page 401 and 402:
402 Chapter | 13 Hepatic Function F
- Page 403 and 404:
404 Chapter | 13 Hepatic Function A
- Page 405 and 406:
406 Chapter | 13 Hepatic Function E
- Page 407 and 408:
408 Chapter | 13 Hepatic Function K
- Page 409 and 410:
410 Chapter | 13 Hepatic Function R
- Page 411 and 412:
412 Chapter | 13 Hepatic Function W
- Page 413 and 414:
414 Chapter | 14 Gastrointestinal F
- Page 415 and 416:
416 Chapter | 14 Gastrointestinal F
- Page 417 and 418:
418 Chapter | 14 Gastrointestinal F
- Page 419 and 420:
420 Chapter | 14 Gastrointestinal F
- Page 421 and 422:
422 Chapter | 14 Gastrointestinal F
- Page 423 and 424:
424 Chapter | 14 Gastrointestinal F
- Page 425 and 426:
426 Chapter | 14 Gastrointestinal F
- Page 427 and 428:
428 Chapter | 14 Gastrointestinal F
- Page 429 and 430:
430 Chapter | 14 Gastrointestinal F
- Page 431 and 432:
432 Chapter | 14 Gastrointestinal F
- Page 433 and 434:
434 Chapter | 14 Gastrointestinal F
- Page 435 and 436:
436 Chapter | 14 Gastrointestinal F
- Page 437 and 438:
438 Chapter | 14 Gastrointestinal F
- Page 439 and 440:
440 Chapter | 14 Gastrointestinal F
- Page 441 and 442:
442 Chapter | 14 Gastrointestinal F
- Page 443 and 444:
444 Chapter | 14 Gastrointestinal F
- Page 445 and 446:
446 Chapter | 14 Gastrointestinal F
- Page 447 and 448:
448 Chapter | 14 Gastrointestinal F
- Page 449 and 450:
450 Chapter | 14 Gastrointestinal F
- Page 451 and 452:
452 Chapter | 14 Gastrointestinal F
- Page 453 and 454:
454 Chapter | 14 Gastrointestinal F
- Page 455 and 456:
456 Chapter | 14 Gastrointestinal F
- Page 457 and 458:
Chapter 15 Skeletal Muscle Function
- Page 459 and 460:
II. Specialization of the Sarcolemm
- Page 461 and 462:
II. Specialization of the Sarcolemm
- Page 463 and 464: III. Heterogeneity of Skeletal Musc
- Page 465 and 466: III. Heterogeneity of Skeletal Musc
- Page 467 and 468: V. Exercise and Adaptations to Trai
- Page 469 and 470: VI. Diagnostic Laboratory Methods f
- Page 471 and 472: VI. Diagnostic Laboratory Methods f
- Page 473 and 474: IX. Selected Neuromuscular Disorder
- Page 475 and 476: IX. Selected Neuromuscular Disorder
- Page 477 and 478: References 479 and, recently, there
- Page 479 and 480: References 481 Engel , A. G. ( 2004
- Page 481 and 482: References 483 Paciello , O. , Maio
- Page 483 and 484: Chapter 16 Kidney Function and Dama
- Page 485 and 486: II. Kidney Morphology and Function
- Page 487 and 488: II. Kidney Morphology and Function
- Page 489 and 490: III. Tests of Kidney Function 491 (
- Page 491 and 492: III. Tests of Kidney Function 493 T
- Page 493 and 494: III. Tests of Kidney Function 495 B
- Page 495 and 496: 6 5 4 3 2 1 0 Dog Cat Equine Cattle
- Page 497 and 498: III. Tests of Kidney Function 499 d
- Page 499 and 500: IV. Tests of Kidney Damage 501 1000
- Page 501 and 502: IV. Tests of Kidney Damage 503 and
- Page 503 and 504: IV. Tests of Kidney Damage 505 Enzy
- Page 505 and 506: V. Biochemical Changes in Kidney Di
- Page 507 and 508: V. Biochemical Changes in Kidney Di
- Page 509 and 510: References 511 were reported to occ
- Page 511 and 512: References 513 Bovee , K. C. ( 1969
- Page 513: References 515 Deguchi , E. , and A
- Page 517 and 518: References 519 Harvey , D. G. ( 197
- Page 519 and 520: References 521 Kühl , S. , Mischke
- Page 521 and 522: References 523 creatinine measureme
- Page 523 and 524: References 525 Reusch , C. , Vochez
- Page 525 and 526: References 527 Terry , R. , Hawkins
- Page 527 and 528: Chapter 17 Fluid, Electrolyte, and
- Page 530 and 531: 532 Chapter | 17 Fluid, Electrolyte
- Page 534 and 535: 536 Chapter | 17 Fluid, Electrolyte
- Page 536 and 537: 538 Chapter | 17 Fluid, Electrolyte
- Page 538 and 539: 540 Chapter | 17 Fluid, Electrolyte
- Page 540 and 541: 542 Chapter | 17 Fluid, Electrolyte
- Page 542 and 543: 544 Chapter | 17 Fluid, Electrolyte
- Page 544 and 545: 546 Chapter | 17 Fluid, Electrolyte
- Page 546 and 547: 548 Chapter | 17 Fluid, Electrolyte
- Page 548 and 549: 550 Chapter | 17 Fluid, Electrolyte
- Page 551 and 552: VIII. Clinicopathological Indicator
- Page 553 and 554: References 555 plasma water, electr
- Page 555 and 556: References 557 Krzywanek , H. ( 197
- Page 557 and 558: References 559 Strombeck , D. R. (1
- Page 559 and 560: 562 Chapter | 18 Pituitary Function
- Page 561 and 562: 564 Chapter | 18 Pituitary Function
- Page 563 and 564: 566 Chapter | 18 Pituitary Function
- Page 565 and 566:
568 Chapter | 18 Pituitary Function
- Page 567 and 568:
570 Chapter | 18 Pituitary Function
- Page 569 and 570:
572 Chapter | 18 Pituitary Function
- Page 571 and 572:
574 Chapter | 18 Pituitary Function
- Page 573 and 574:
576 Chapter | 18 Pituitary Function
- Page 575 and 576:
578 Chapter | 18 Pituitary Function
- Page 577 and 578:
580 Chapter | 18 Pituitary Function
- Page 579 and 580:
582 Chapter | 18 Pituitary Function
- Page 581 and 582:
584 Chapter | 18 Pituitary Function
- Page 583 and 584:
586 Chapter | 18 Pituitary Function
- Page 585 and 586:
588 Chapter | 18 Pituitary Function
- Page 587 and 588:
590 Chapter | 18 Pituitary Function
- Page 589 and 590:
592 Chapter | 18 Pituitary Function
- Page 591 and 592:
594 Chapter | 18 Pituitary Function
- Page 593 and 594:
596 Chapter | 18 Pituitary Function
- Page 595 and 596:
598 Chapter | 18 Pituitary Function
- Page 597 and 598:
600 Chapter | 18 Pituitary Function
- Page 599 and 600:
602 Chapter | 18 Pituitary Function
- Page 601 and 602:
604 Chapter | 18 Pituitary Function
- Page 603 and 604:
606 Chapter | 19 Adrenocortical Fun
- Page 605 and 606:
608 Chapter | 19 Adrenocortical Fun
- Page 607 and 608:
610 Chapter | 19 Adrenocortical Fun
- Page 609 and 610:
612 Chapter | 19 Adrenocortical Fun
- Page 611 and 612:
614 Chapter | 19 Adrenocortical Fun
- Page 613 and 614:
616 Chapter | 19 Adrenocortical Fun
- Page 615 and 616:
618 Chapter | 19 Adrenocortical Fun
- Page 617 and 618:
620 Chapter | 19 Adrenocortical Fun
- Page 619 and 620:
622 Chapter | 19 Adrenocortical Fun
- Page 621 and 622:
624 Chapter | 20 Thyroid Function a
- Page 623 and 624:
626 Chapter | 20 Thyroid Function t
- Page 625 and 626:
628 Chapter | 20 Thyroid Function A
- Page 627 and 628:
630 Chapter | 20 Thyroid Function S
- Page 629 and 630:
632 Chapter | 20 Thyroid Function a
- Page 631 and 632:
634 Chapter | 20 Thyroid Function O
- Page 633 and 634:
636 Chapter | 21 Clinical Reproduct
- Page 635 and 636:
638 Chapter | 21 Clinical Reproduct
- Page 637 and 638:
640 Chapter | 21 Clinical Reproduct
- Page 639 and 640:
642 Chapter | 21 Clinical Reproduct
- Page 641 and 642:
644 Chapter | 21 Clinical Reproduct
- Page 643 and 644:
646 Chapter | 21 Clinical Reproduct
- Page 645 and 646:
648 Chapter | 21 Clinical Reproduct
- Page 647 and 648:
650 Chapter | 21 Clinical Reproduct
- Page 649 and 650:
652 Chapter | 21 Clinical Reproduct
- Page 651 and 652:
654 Chapter | 21 Clinical Reproduct
- Page 653 and 654:
656 Chapter | 21 Clinical Reproduct
- Page 655 and 656:
658 Chapter | 21 Clinical Reproduct
- Page 657 and 658:
660 Chapter | 21 Clinical Reproduct
- Page 659 and 660:
662 Chapter | 21 Clinical Reproduct
- Page 661 and 662:
664 Chapter | 22 Trace Minerals the
- Page 663 and 664:
666 Chapter | 22 Trace Minerals the
- Page 665 and 666:
668 Chapter | 22 Trace Minerals P i
- Page 667 and 668:
670 Chapter | 22 Trace Minerals be
- Page 669 and 670:
Copper Cuproreductase Cytochromes C
- Page 671 and 672:
674 Chapter | 22 Trace Minerals 2 .
- Page 673 and 674:
676 Chapter | 22 Trace Minerals Cor
- Page 675 and 676:
678 Chapter | 22 Trace Minerals inf
- Page 677 and 678:
680 Chapter | 22 Trace Minerals tis
- Page 679 and 680:
682 Chapter | 22 Trace Minerals VI
- Page 681 and 682:
684 Chapter | 22 Trace Minerals red
- Page 683 and 684:
686 Chapter | 22 Trace Minerals of
- Page 685 and 686:
688 Chapter | 22 Trace Minerals Per
- Page 687 and 688:
690 Chapter | 22 Trace Minerals In
- Page 689 and 690:
692 Chapter | 22 Trace Minerals Liu
- Page 691 and 692:
Chapter 23 Vitamins Robert B. Rucke
- Page 693 and 694:
III. Fat-Soluble Vitamins 697 TABLE
- Page 695 and 696:
III. Fat-Soluble Vitamins 699 Carot
- Page 697 and 698:
III. Fat-Soluble Vitamins 701 Major
- Page 699 and 700:
III. Fat-Soluble Vitamins 703 doses
- Page 701 and 702:
III. Fat-Soluble Vitamins 705 Diet
- Page 703 and 704:
III. Fat-Soluble Vitamins 707 conta
- Page 705 and 706:
III. Fat-Soluble Vitamins 709 immun
- Page 707 and 708:
IV. Water-Soluble Vitamins 711 are
- Page 709 and 710:
IV. Water-Soluble Vitamins 713 abil
- Page 711 and 712:
IV. Water-Soluble Vitamins 715 5’
- Page 713 and 714:
IV. Water-Soluble Vitamins 717 H 2
- Page 715 and 716:
IV. Water-Soluble Vitamins 719 Enzy
- Page 718 and 719:
722 Chapter | 23 Vitamins When biot
- Page 720 and 721:
724 Chapter | 23 Vitamins Cyanocoba
- Page 722 and 723:
726 Chapter | 23 Vitamins V . VITAM
- Page 724 and 725:
728 Chapter | 23 Vitamins nature, r
- Page 726 and 727:
730 Chapter | 23 Vitamins Stites ,
- Page 728 and 729:
732 Chapter | 24 Lysosomal Storage
- Page 730 and 731:
734 Chapter | 24 Lysosomal Storage
- Page 732 and 733:
736 Chapter | 24 Lysosomal Storage
- Page 734 and 735:
738 Chapter | 24 Lysosomal Storage
- Page 736 and 737:
740 Chapter | 24 Lysosomal Storage
- Page 738 and 739:
742 Chapter | 24 Lysosomal Storage
- Page 740 and 741:
744 Chapter | 24 Lysosomal Storage
- Page 742 and 743:
746 Chapter | 24 Lysosomal Storage
- Page 744 and 745:
748 Chapter | 24 Lysosomal Storage
- Page 746 and 747:
Chapter 25 Tumor Markers Michael D.
- Page 748 and 749:
II. Serum Tumor Markers 753 also be
- Page 750 and 751:
III. Flow Cytometry 755 cancer of t
- Page 752 and 753:
V. Immunohistochemistry/Immunocytoc
- Page 754 and 755:
V. Immunohistochemistry/Immunocytoc
- Page 756 and 757:
References 761 analysis will facili
- Page 758 and 759:
References 763 Fernandez , N. J. ,
- Page 760 and 761:
References 765 Meinecke , B. , and
- Page 762 and 763:
References 767 Walter , J. ( 2000 )
- Page 764 and 765:
770 Chapter | 26 Cerebrospinal Flui
- Page 766 and 767:
772 Chapter | 26 Cerebrospinal Flui
- Page 768 and 769:
774 Chapter | 26 Cerebrospinal Flui
- Page 770 and 771:
776 Chapter | 26 Cerebrospinal Flui
- Page 772 and 773:
778 Chapter | 26 Cerebrospinal Flui
- Page 774 and 775:
TABLE 26-7 Continued Constituent Ro
- Page 776 and 777:
782 Chapter | 26 Cerebrospinal Flui
- Page 778 and 779:
784 Chapter | 26 Cerebrospinal Flui
- Page 780 and 781:
786 Chapter | 26 Cerebrospinal Flui
- Page 782 and 783:
788 Chapter | 26 Cerebrospinal Flui
- Page 784 and 785:
790 Chapter | 26 Cerebrospinal Flui
- Page 786 and 787:
792 Chapter | 26 Cerebrospinal Flui
- Page 788 and 789:
794 Chapter | 26 Cerebrospinal Flui
- Page 790 and 791:
796 Chapter | 26 Cerebrospinal Flui
- Page 792 and 793:
798 Chapter | 26 Cerebrospinal Flui
- Page 794 and 795:
800 Chapter | 26 Cerebrospinal Flui
- Page 796 and 797:
802 Chapter | 26 Cerebrospinal Flui
- Page 798 and 799:
804 Chapter | 26 Cerebrospinal Flui
- Page 800 and 801:
806 Chapter | 26 Cerebrospinal Flui
- Page 802 and 803:
808 Chapter | 26 Cerebrospinal Flui
- Page 804 and 805:
810 Chapter | 26 Cerebrospinal Flui
- Page 806 and 807:
812 Chapter | 26 Cerebrospinal Flui
- Page 808 and 809:
814 Chapter | 26 Cerebrospinal Flui
- Page 810 and 811:
816 Chapter | 26 Cerebrospinal Flui
- Page 812 and 813:
818 Chapter | 26 Cerebrospinal Flui
- Page 814 and 815:
Chapter 27 Clinical Biochemistry in
- Page 816 and 817:
II. Hepatotoxicity 823 Therefore, A
- Page 818 and 819:
III. Nephrotoxicity 825 suggested a
- Page 820 and 821:
IV. Toxins Affecting Skeletal and C
- Page 822 and 823:
VII. Toxins Affecting Erythrocytes
- Page 824 and 825:
VIII. Toxins Affecting Hemoglobin a
- Page 826 and 827:
IX. Toxins Affecting the Nervous Sy
- Page 828 and 829:
References 835 Plants classified as
- Page 830 and 831:
References 837 Solaiman , S. G. , M
- Page 832 and 833:
840 Chapter | 28 Avian Clinical Bio
- Page 834 and 835:
842 Chapter | 28 Avian Clinical Bio
- Page 836 and 837:
844 Chapter | 28 Avian Clinical Bio
- Page 838 and 839:
846 Chapter | 28 Avian Clinical Bio
- Page 840 and 841:
848 Chapter | 28 Avian Clinical Bio
- Page 842 and 843:
850 Chapter | 28 Avian Clinical Bio
- Page 844 and 845:
Budgerigar ALAT (IU/g tissue) Budge
- Page 846 and 847:
854 Chapter | 28 Avian Clinical Bio
- Page 848 and 849:
856 Chapter | 28 Avian Clinical Bio
- Page 850 and 851:
858 Chapter | 28 Avian Clinical Bio
- Page 852 and 853:
860 Chapter | 28 Avian Clinical Bio
- Page 854 and 855:
862 Chapter | 28 Avian Clinical Bio
- Page 856 and 857:
864 Chapter | 28 Avian Clinical Bio
- Page 858 and 859:
866 Chapter | 28 Avian Clinical Bio
- Page 860 and 861:
868 Chapter | 28 Avian Clinical Bio
- Page 862 and 863:
870 Chapter | 28 Avian Clinical Bio
- Page 864 and 865:
872 Chapter | 28 Avian Clinical Bio
- Page 866 and 867:
874 Appendix | I SI Units TABLE E S
- Page 868 and 869:
Appendix II Conversion Factors of S
- Page 870 and 871:
Appendix IV Stability of Serum Enzy
- Page 872 and 873:
Appendix VI Nomogram for Computing
- Page 874 and 875:
t0100 Appendix VIII Blood Analyte R
- Page 876 and 877:
884 Appendix | VIII Blood Analyte R
- Page 878 and 879:
886 Appendix | VIII Blood Analyte R
- Page 880 and 881:
888 Appendix | VIII Blood Analyte R
- Page 882 and 883:
890 Appendix | IX Blood Analyte Ref
- Page 884 and 885:
892 Appendix | IX Blood Analyte Ref
- Page 886 and 887:
894 Appendix | IX Blood Analyte Ref
- Page 888 and 889:
Appendix X Blood Analyte Reference
- Page 890 and 891:
Appendix XI Blood Analyte Reference
- Page 892 and 893:
Appendix XII Urine Analyte Referenc
- Page 894 and 895:
902 Appendix | XIII Cerebrospinal F
- Page 896:
904 Appendix | XIV Cerebrospinal Fl